PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg)

PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg) is a lyophilized research peptide synthesized, purified, and lyophilized in the USA. Each production batch is purified by repeated rounds of reverse-phase HPLC and identity-confirmed by mass spectrometry.

PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg) is often screened alongside other matrix peptides to compare activity profiles in vitro.

Laboratory work on PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg) emphasizes controlled concentration studies and reproducible assay conditions.

Current evaluation of PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg) explores its compatibility with common formulation excipients used in cosmetic research.

Each vial contains lyophilized peptide at the labeled quantity, and wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only —not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with PAL-GHK (Palmitoyl Tripeptide-1) Topical (200mg). Summaries are provided for orientation only and reflect the cited sources.

Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream^[1] —This study comprehensively evaluated the efficacy and safety of a multi-component anti-aging eye cream containing palmitoyl tripeptide-1 (PAL-GHK) together with palmitoyl tetrapeptide-7. Over a 12-week clinical assessment, the authors measured parameters such as hydration, elasticity, and collagen density in the eye area. They reported improvements in these measures, indicating that the formulation may benefit the delicate periorbital skin. (Skin Research and Technology 2024)

Role of topical peptides in preventing or treating aged skin^[2] —This review discusses palmitoylated signal peptides, including palmitoyl tripeptide-1 (PAL-GHK), among collagen-stimulating cosmetic actives. The authors evaluate how such peptides may stimulate collagen synthesis in aged skin. They consider the clinical evidence and mechanisms relevant to anti-aging product claims. (International Journal of Cosmetic Science 2009)

Cosmeceutical peptides^[3] —This review discusses the class of cosmeceutical peptides, including signal peptides such as palmitoyl tripeptide-1. The authors describe evidence suggesting that these peptides can stimulate collagen production and improve skin appearance. They position such ingredients within the broader landscape of peptide-based cosmetic actives. (Dermatologic Therapy 2007)

References

1. Yang F, Zhang X, Wang H, Guo M, Zhang J, Feng X, Yu J, Yang J, Zhu J, Wang Y. "Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream." Skin Research and Technology. 2024. pubmed.ncbi.nlm.nih.gov/38932444/
2. Gorouhi F, Maibach HI. "Role of topical peptides in preventing or treating aged skin." International Journal of Cosmetic Science. 2009. pubmed.ncbi.nlm.nih.gov/19570099/
3. Lupo MP, Cole AL. "Cosmeceutical peptides." Dermatologic Therapy. 2007. pubmed.ncbi.nlm.nih.gov/18045359/

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.